Pregnancy Outcomes After Human Papillomavirus Vaccination in Periconceptional Period or During Pregnancy: A Systematic Review and Meta-analysis
Background: National immunization schedules in many countries recommend HPV vaccination for females until the age of 26 years, and thus substantial numbers with reproductive age may be exposed to HPV vaccines. Objective: To assess whether inadvertent HPV vaccine exposures in the periconceptional per...
Main Authors: | Anshi Wang, Chang Liu, Yunan Wang, Aihua Yin, Jing Wu, Changbin Zhang, Mingyong Luo, Li Du, Ying Xiong, Xin Zhao, Yanlin Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-03-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2019.1662363 |
Similar Items
-
Association of periconceptional or pregnancy exposure of HPV vaccination and adverse pregnancy outcomes: a systematic review and meta-analysis with trial sequential analysis
by: Xiaoli Yan, et al.
Published: (2023-05-01) -
Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine
by: Lina S. Sy, et al.
Published: (2018-02-01) -
Human papillomavirus and pregnancy: A narrative review study
by: Azam Shafaei, et al.
Published: (2024-04-01) -
Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
by: Guohua Zhong, et al.
Published: (2023-12-01) -
Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study
by: Kandace L. Amend, et al.
Published: (2022-11-01)